We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£885.00
It has never been this cheap. We have no record of a lower price.
£885 today · cheaper than every other day in the last 2 months
The 2026-2031 World Outlook for Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 7 days · 7 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 7 days • 1 price levels
Price Analysis
Most common price: £885 (7 days, 100.0%)
Price range: £885 - £885
Price levels: 1 different prices over 7 days
Product Specifications
- Format
- paperback
- ASIN
- B0FFSHP2D7
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 04 June 2025
- Listed Since
- 27 June 2025
Similar Products You Might Like
The 2026-2031 World Outlook for Lysosomal Storage Diseases Therapeutics
The 2026-2031 World Outlook for Oligonucleotide Therapeutics
The 2026-2031 World Outlook for Liver Cancer Diagnostics
The 2026-2031 World Outlook for Lysosomal Storage Diseases Treatments
The 2026-2031 World Outlook for Oligonucleotide Therapeutics for Neurological Disorders
The 2026-2031 World Outlook for Kidney Cancer Drugs
The 2026-2031 World Outlook for Premetrexed and Combinations for Malignant Mesothelioma
The 2026-2031 World Outlook for Lysosomal Storage Diseases
The 2026-2031 World Outlook for Human Serum Albumin
The 2026-2031 World Outlook for Malignant Mesothelioma
The 2026-2031 World Outlook for Combination Antibody Therapies
The 2026-2031 World Outlook for Albumin
The 2026-2031 World Outlook for Bone Morphogenetic Proteins
The 2026-2031 World Outlook for Hydroxychloroquine
The 2026-2031 World Outlook for Renal Anemia Treatments
The 2026-2031 World Outlook for Biotherapeutics Cell Line Transfection and Selection
The 2026-2031 World Outlook for Exocrine Pancreatic Insufficiency Therapeutics
The 2026-2031 World Outlook for Primary Immunodeficiency Diseases
The 2026-2031 World Outlook for Kinase Inhibitors
The 2026-2031 World Outlook for Chronic Obstructive Pulmonary Disease Treatments
The 2026-2031 World Outlook for Cell Line Developments
The 2026-2031 World Outlook for Somatostatin Analogs Treatments
The 2026-2031 World Outlook for Adult Stem Cells
